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Sleep disorders are prevalent in chronic kidney disease
patients, although the underlying mechanisms are not
understood. The current study demonstrates that
adenine-induced tubulointerstitial nephropathy dis-
rupted the circadian system both centrally and in pe-
ripheral organs. Clock mutant mice were also more
vulnerable to the effects of adenine. These findings aid
the understanding of sleep disturbances in adenine
phosphoribosyltransferase deficiency, a rare inherited
metabolic disorder that leads to the accumulation of 2,8-
dihydroxyadenine. More broadly, the results suggest
that circadian disruption caused by environmental fac-
tors such as nighttime shift work may be a risk factor for
chronic kidney disease development.Chronic Kidney Disease (CKD) is increasing in incidence and
has become a worldwide health problem. Sleep disorders
are prevalent in patients with CKD raising the possibility
that these patients have a disorganized circadian timing
system. Here, we examined the effect of adenine-induced
tubulointerstitial nephropathy on the circadian system in
mice. Compared to controls, adenine-treated mice showed
serum biochemistry evidence of CKD as well as increased
kidney expression of inflammation and fibrosis markers.
Mice with CKD exhibited fragmented sleep behavior and
locomotor activity, with lower degrees of cage activity
compared to mice without CKD. On a molecular level, mice
with CKD exhibited low amplitude rhythms in their central
circadian clock as measured by bioluminescence in slices of
the suprachiasmatic nucleus of PERIOD 2::LUCIFERASE
mice. Whole animal imaging indicated that adenine treated
mice also exhibited dampened oscillations in intact kidney,
liver, and submandibular gland. Consistently, dampened
circadian oscillations were observed in several circadian
clock genes and clock-controlled genes in the kidney of the
mice with CKD. Finally, mice with a genetically disrupted
circadian clock (Clock mutants) were treated with adenine
and compared to wild type control mice. The treatment
evoked worse kidney damage as indicated by higher
deposition of gelatinases (matrix metalloproteinase-2 and
9) and adenine metabolites in the kidney. Adenine also
caused non-dipping hypertension and lower heart rate.
Thus, our data indicate that central and peripheral
circadian clocks are disrupted in the adenine-treated mice,
and suggest that the disruption of the circadian clock
accelerates CKD progression.
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Elsevier Inc. All rights reserved.T he number of dialysis patients has been increasingaround the world, and chronic kidney disease (CKD)has become a global health issue.1 Currently, there is no
cure for CKD, and treatment options, including kidney
transplantation or a lifetime of dialysis, are limited. Further,
CKD patients have a high risk of complications, including
stroke,2 cardiovascular disease,3 fractures,4 and sarcopenia.5
Therefore, it is important to investigate approaches to
reduce the risk of CKD early in the disease progression.
Several studies have reported that CKD patients show frag-
mentation of sleep, shorter sleep duration, poor sleep quality,
and difficulties in the timing of sleep.6 More than 50% of
CKD patients suffer from daytime sleepiness.7 Clinical reports
show abnormal electroencephalogram patterns in CKD pa-
tients during wakefulness, especially at the later stages of the
disease,8 and a positive correlation between the abnormal
electroencephalogram and serum (blood) urea nitrogen
(BUN) has been reported.9 These studies raise the possibilityKidney International (2020) 97, 728–740
H Motohashi et al.: Clock disruption in tubulointerstitial nephropathy ba s i c re sea r chthat the circadian timing system may be disrupted in CKD
patients.
The circadian system controls daily fluctuation of physi-
ological functions in mammals. The central clock, located in
the suprachiasmatic nucleus (SCN) of the hypothalamus,
regulates the peripheral clocks located in each organ to
generate physiological rhythms.10–12 In the cellular circadian
clocks, CLOCK/BMAL1 works as a transcriptional activator
to initiate transcription of the Per1/2/3 and Cry1/2 genes, and
the PER/CRY complex inhibits transcriptional activity of
CLOCK/BMAL1 on a cycle approximating 24 hours. Retinoic
acid–related orphan receptor (ROR) and REV-ERBa/b acti-
vate and suppress Bmal1 transcription, respectively, to
augment the 24-hour rhythm. Clock-controlled PAR-domain
basic leucine zipper transcription factors albumin D-box
binding protein (DBP), thyrotroph embryonic factor (TEF),
and hepatic leukemia factor (HLF) are highly expressed in the
kidney with circadian rhythmicity, and they regulate renal
functional genes, such as key regulators of water and sodium
balance including the vasopressin V2 receptor (V2r),
aquaporin-2 (Aqp2), Aqp4, and endothelial sodium channel a
(aENaC).13 It is well known that renal functions, including
homeostatic control of water, electrolyte balance, and eryth-
ropoietin levels, show circadian rhythmicity.14 Mice with a
genetically disrupted circadian timing system (e.g., Clock
mutant mice) exhibit both nocturia and nocturnal polyuria
with lower expressions of several renal genes.15 These studies
suggest that the circadian system is deeply involved in renal
function.
Adenine-induced tubulointerstitial nephropathy in ro-
dents has been established as a strong model of renal
dysfunction without the complications of surgery or
increased mortality seen in other CKD models, such as
unilateral ureteral obstruction and nephrectomy.16 Normally,
adenine is converted into the uric acid allantoin, which is
excreted with urine. However, excess adenine accumulates
and is converted into 8-dihydroxy adenine, then eventually
2,8-dihydroxy adenine, and these non-soluble materials
crystallize in renal tubules and cause damage. After feeding
of an adenine (0.2%)–containing casein-based diet for 2–4
weeks, inflammation and fibrosis are detected in the kidney,
and the serum markers of renal dysfunction are elevated
(BUN and creatinine).16 However, the impact of adenine on
circadian function is not known and is the focus of the
present study. First, we analyzed the impact of CKD on
locomotor activity, and video-analyzed sleep behavior, food/
water intake, and urine volume. Next, we determined the
impact of CKD on the rhythms of clock gene expression
measured by PER2 bioluminescence. We also measured
rhythms in gene expression using real-time polymerase
chain reaction by sampling the kidney every 4 hours
through the 24-hour cycle. Finally, we determined if the
genetic disruption of the circadian clock (Clock mutant)
rendered the mice more sensitive to renal damage due to the
adenine diet.Kidney International (2020) 97, 728–740RESULTS
Adenine-treated mice exhibit disrupted renal function
consistent with CKD
After 2 weeks of the adenine diet (Figure 1a), ICR mice
showed decreased body weight compared with control mice
(Figure 1b). Indicators of renal function, including BUN,
serum and urine creatinine, and the anti-inflammatory hor-
mone corticosterone, were found to be increased in the CKD
group (Figure 1c–g). The amount and frequency of water
intake was higher in both the day and night (Figure 1h). In
contrast, food intake was not changed by adenine treatment
(Figure 1i). As with drinking behavior, diminished day–night
variations of urine total volume, sodium, and potassium were
seen in the adenine-treated mice (Figure 1j). The disruption
of the day–night difference in urine volume and its contents
suggest that the circadian regulation of renal function is dis-
rupted in the treated mice.
CKD mice exhibit disrupted behavioral activity and sleep
rhythms
Next, we measured daily rhythms of locomotor activity and
sleep behavior as circadian output using infrared sensors
(activity) and video-monitored immobility (sleep), respec-
tively, using C57BL/6N male mice. At first, we confirmed
serum and urine creatinine changes in this strain
(Supplementary Figure S1A). Compared to control mice, the
CKD mice showed less locomotor activity in the night, with
an increased number of activity bouts (Figure 2a–c). A 2-way
repeated measures analysis of variance run on the waveform
(1 hour bins) confirmed significant effects of time (F[23,
322] ¼ 63.56, P < 0.001) and treatment (F[1, 14] ¼ 5.11, P <
0.001), and an interaction (F[23, 322] ¼ 3.32, P < 0.001).
The % activity in the light phase was also greater in the CKD
group (11.5%  1.3% in the control group and 20.8% 
2.1% in the CKD group, P < 0.01 by Student’s t test). Despite
these changes, the strength of the activity rhythm as measured
by periodogram analysis did not vary with treatment (39.0%
 1.6% in the control group and 32.8%  4.0% in the CKD
group). A similar reduction of activity level and increase in
activity bouts were seen in the male ICR strain
(Supplementary Figure S2A–C). The amount of sleep
behavior was not impacted by the treatment (Figure 2d and
e). The CKD mice had a higher number of sleep bouts in their
rest-phase (Figure 2f). Thus, the CKD mice exhibited reduced
locomotor activity as well as more fragmented rhythms in
sleep.
CKD mice exhibited low-amplitude rhythms in PER2-driven
bioluminescence measured from the central circadian clock
(SCN)
Rhythms in activity and sleep are controlled by the SCN.12
Therefore, we next sought to determine whether the PER2
protein rhythms measured in the SCN were disrupted in the
CKD mice. Brain slices containing the SCN were prepared
from PER2::LUCIFERASE mice (ICR background) treated
with the adenine diet. We found that the SCN from the CKD729
Figure 1 | Day–night differences in water/food intake and urine in adenine-induced mice with adenine-induced chronic kidney
disease (CKD). (a) Experimental schedule: mice were fed a control (AIN 93N) or adenine (0.2%)-containing diet for 2 weeks. At this point,
(b) body weight (B.W.), (c) blood urea nitrogen (BUN) in serum, (d) serum creatinine, and (e) urine creatinine were measured at ZT6
(Zeitgeber time; ZT0 is the time of light on and ZT12 is the time of light off); n ¼ 5–7 per group. (f,g) BUN and serum corticosterone were
measured at 4 time points per day (n ¼ 4 in each for BUN, n ¼ 6 in each for corticosterone). (h,i) Water or food intake was measured
every 4 hours (left) or 12 hours (middle), and the frequency of intake is shown in the right panel (n ¼ 7 per group). The dark shadows indicate
the time of lights-off (ZT12-24). (j) Urine volume (left), total urine Na (middle), and total urine K (right) were measured every 12 hours in
metabolic cages (n ¼ 5–7 per group). Water, food, and urine are normalized to B.W. All values are expressed as individual plots with mean 
SEM. P values, versus control: *P < 0.05; **P < 0.01; ***P < 0.001.
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Figure 2 | Cage activity and sleep behavior in adenine-induced mice with adenine-induced chronic kidney disease (CKD). After 2
weeks of control (Ctl) or adenine (CKD) diet treatment to C57BL/6N male mice, cage activity (a–c) and sleep behavior (d–f) were measured by
infrared sensor and video monitoring, respectively (n ¼ 8 in each group). Time-series data of activity or sleep are shown with individual
plots (upper panels in a,d), 1-hour bins (lower panels in a,d), and 12-hour bins (b,e). Activity or sleep bout numbers are shown in (c) and (f).
The dark shadows indicate the time of lights-off (Zeitgeber time; ZT0 is the time of light on and ZT12 is the time of light off; ZT12–24). All
values are expressed as individual plots with mean  SEM. P values, versus control: *P < 0.05; **P < 0.01.
H Motohashi et al.: Clock disruption in tubulointerstitial nephropathy ba s i c re sea r chmice exhibited low-amplitude rhythms that damped faster
than that in controls (Figure 3a–e). The endogenous circadian
cycle length (period) was not altered, nor did we observe any
differences in the peak phase of the bioluminescence rhythms
(Figure 3d and e). Our data suggest that CKD weakens the
amplitude but not the period or phase of the central circadian
clock.
CKD mice exhibited low-amplitude rhythms in PER2-driven
bioluminescence measured from peripheral organs in vivo
Next, using in vivo imaging techniques,17 we examined
PER2::LUC bioluminescence from kidneys, liver, and sub-
mandibular gland throughout the 24-hour cycle (Figure 4a
and b). We found that the daily average of bioluminescence
and amplitude of the rhythms were reduced in all 3 tissues,
whereas peak phase was unaltered (Figure 4c–e). We also
measured PER2::LUC bioluminescence from kidney explants
in vitro. Interestingly, we found that the rhythms in biolu-
minescence were not compromised in the CKD mice under
these condition (Supplementary Figure S3). These findingsKidney International (2020) 97, 728–740suggest that the molecular clockwork in the intact organism is
more impacted by CKD than the clockwork in the isolated
kidney. Sex differences of CKD patients and CKD model
animals are reported, with greater adverse effects in
males.18,19 Consistently, compared with males (Figures 1
and 4), in female mice (Supplementary Figure S4), we
found smaller effects on urine creatinine levels (71% reduc-
tion by adenine in females, 81% reduction in males) and
in vivo renal PER2::LUC rhythms (31% reduction in females,
55% reduction in males).
CKD mice exhibited low-amplitude rhythms in clock gene
expression measured from the kidney
To get a more complete view, we used real-time polymerase
chain reaction to measure the expression levels of clock genes
sampled every 4 hours throughout the 24-hour cycle. The
expression levels were reduced at several time points in all
clock genes except for Dec1 and Cry1 (Figure 5a). In addition,
mRNA levels of renal function genes (Scnn1a, Gilz, Aqp2,
V2r), which were reported to be regulated by the circadian731
Figure 3 | PER2::LUCIFERASE (PER2::LUC) rhythms in the suprachiasmatic nucleus (SCN) of mice with adenine-induced chronic kidney
disease (CKD). After 2 weeks of control (Ctl) or adenine (CKD) diet treatment, PER2::LUC activity was measured in vitro. (a) Representative
PER2::LUC activity (photon [p]/min in a dish) from brain slices containing the SCN. Raw data (left) and detrended data (right) are shown
(n ¼ 7 in each group). (b) Shown are amplitude, (c) amplitude change, (d) period, and (e) peak phase of the SCN PER2::LUC rhythms. The
amplitude of first peak is set as 100% in (c). All values are expressed as individual plots with mean  SEM. P values, versus control: *P < 0.05.
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of the circadian clock or clock-regulated genes that we
examined showed significant rhythmicity in both control and
CKD conditions (Supplementary Table S1). Some of them
showed phase changes by CKD, but the direction of the phase
changes depended on the genes (Supplementary Table S1). In
contrast, inflammation (Mmp2, Mmp9, Il-1b) and fibrosis
(Tgf-b1) markers were increased significantly throughout the
day and night (Figure 5c). Similar results were seen in the
C57BL/6N CKD mice for Rev-erba, Tef, and Tgf-b1, but not
Per2 (Supplementary Figure S1). The gene expression data
indicate that the molecular clock and its rhythmic outputs in
the kidney are damped while inflammation is chronically
increased in the CKD condition.
Disruption of clock and renal function did not reverse after 2
weeks of recovery
We examined whether the renal gene expression changes in
CKD mice would reverse themselves after a return to the
normal diet from the adenine diet (Supplementary Figure S5).
After 2 weeks of recovery, BUN and urine creatinine levels
were slightly recovered but still significantly different from
those in control mice. The expression level of clock genes
(Per2, Clock, Rev-erba, Dbp) and the clock-controlled gene
(Scnn1a) stayed dampened compared with the controls. Tgf-
b1, a marker of fibrosis, showed constantly high levels of
mRNA as well. These observations suggest that dampened
molecular clocks persist after establishment of CKD.
Clock mutation made mice vulnerable to the impact of the
adenine diet
A variety of studies suggest that a robust circadian rhythm is
important for health and that environmental or genetic732disruptions of the circadian system can accelerate disease
progression.12,20,21 Therefore, we examined the impact of
Clock⊿19/⊿19 mutation, in which exon 19 (51 amino acids) is
missing and dominant-negative protein is expressed,22 on the
development of adenine-induced CKD (Figures 6–8). Clock
mutant mice showed a significantly lower level of urine
creatinine on days 9 and 13, and an earlier increase of serum
BUN levels on days 5 and 9 compared with wild-type (WT)
mice (Figure 6a and b). Serum creatinine or urine osmolarity
were not different between genotypes (Figure 6c and d). Renal
hematoxylin and eosin, and Masson trichrome, staining
confirmed adenine-induced tubular damage and showed
significantly higher 2,8-dehydroxyadenine deposition in Clock
mutant mice compared to WTmice, but other factors (distal
tubular dilation and fibrosis) were not different between ge-
notypes (Figure 6e–g). As reported previously,13,15 Clock
mutant mice showed a higher volume of total urine (cor-
rected by body weight) with increased daytime urine excre-
tion in the control diet condition (Figure 6h). The treated
mutants exhibited significantly increased urine excretion and
urine sodium/potassium content during both day and night,
compared with WT CKD mice (Figure 6h). After 2 weeks of
adenine treatment, daily gene expression changes were
measured (Figure 7a and Supplementary Figure S6A). Mmp2/
9, but not Tgf-b1, expression was significantly increased
compared with that in WT mice in CKD conditions. For
Mmp2, a 2-way analysis of variance revealed significant effects
of treatment (F[1, 60] ¼ 167.2, P < 0.001) and genotype (F[1,
60] ¼ 10.45, P < 0.01), and an interaction (F[1, 60] ¼ 4.18,
P < 0.05). For Mmp9, a 2-way analysis of variance confirmed
significant effects of treatment (F[1, 60] ¼ 106.5, P < 0.001)
and genotype (F[1, 60] ¼ 29.47, P < 0.001), and an
interaction (F[1, 60] ¼ 4.81, P < 0.05). Although theKidney International (2020) 97, 728–740
Figure 4 | PER2::LUCIFERASE (PER2::LUC) rhythms in the peripheral tissues of mice with adenine-induced chronic kidney disease
(CKD). After 2 weeks of control (Ctl) or adenine (CKD) diet treatment, PER2::LUC activity was measured utilizing in vivo monitoring methods.
(a) Representative photographs of in vivo PER2::LUC imaging in the kidney, liver, and submandibular gland (Sub gla) taken every 4 hours
are shown (n ¼ 4 in each group). (b) Individual (upper) or averaged (lower) PER2::LUC activity rhythms (photon [p]/sec from the tissues) in the
peripheral tissues. The dark shadows indicate the time of lights-off (Zeitgeber time; ZT0 is the time of light on and ZT12 is the time of
light off; ZT12–24). (c) Shown are daily average of bioluminescence, (d) amplitude, and (e) peak phase of peripheral PER2::LUC rhythms. All
values are expressed as individual plots with mean  SEM. P values, versus control: *P < 0.05; **P < 0.01.
H Motohashi et al.: Clock disruption in tubulointerstitial nephropathy ba s i c re sea r ch2,8-dehydroxyadenine deposition was higher in the mutant,
Xanthine dehydrogenase (Xdh), which produces insoluble 2,8-
dehydroxyadenine, was increased in the liver in both adenine-
treated WT and mutant mice with no genotype difference
(Figure 7a). Consistently, matrix metalloproteinase 2
(MMP2) protein level and gelatinase activity of pro-MMP2
were higher in the mutant mice, measured by western blot-
ting and zymography, respectively (Figure 7b–d). In sum-
mary, our data suggest that the Clock mutation potentiated
the progression of adenine-induced CKD and led to wors-
ening of symptoms due to the higher 2,8-dehydroxyadenine
deposition and MMP2 expression.Kidney International (2020) 97, 728–740Adenine-treated Clock mutant mice exhibited hypertension
and reduced heart rate, with disrupted circadian rhythmicity
The effects of adenine treatment and Clock mutation on heart
rate and blood pressure were examined using a telemetry
system and the tail-cuff method (Figure 8). Under control
conditions, the Clock mutant mice showed a phase delayed
rise in diurnal rhythm in blood pressure, heart rate, and ac-
tivity (Figure 8a; cosinor analysis and 2-way repeated mea-
sures analysis of variance are indicated in Supplementary
Tables S2 and S3, respectively), as previously reported.23
After 2 weeks of adenine treatment, systolic blood pressure
was increased compared to controls, and the normal733
Figure 5 | Renal gene expression rhythms in mice with adenine-induced chronic kidney disease (CKD). Daily mRNA expression of clock
genes (a), clock-controlled renal genes (b), and renal inflammation or fibrosis markers (c) were measured after 2 weeks of control (Ctl) or
adenine (CKD) diet treatment (n ¼ 4 in each time point). The dark shadows indicate the times of lights-off (Zeitgeber time; ZT0 is the time of
light on and ZT12 is the time of light off; ZT12–24). All values are expressed as individual plots with mean  SEM. P values versus
control at each time point: *P < 0.05; **P < 0.01; ***P < 0.001.
bas i c re sea r ch H Motohashi et al.: Clock disruption in tubulointerstitial nephropathyday–night difference was disrupted with non-dipping at rest
phase, analyzed by the goodness-of-fit value of cosinor
analysis and the percent difference between day and night
(Figure 8a; Supplementary Tables S2 and S3). Hypertension
was confirmed using a tail-cuff blood pressure measurement,
and the mutant CKD mice showed higher blood pressure
compared to WT CKD mice at ZT14-18 (Figure 8b). The
heart rate in the mutant mice was lower than that in controls
and exhibited a disrupted daily rhythm (Figure 8a). Similar to
the locomotor activity data measured by infrared sensor
(Figure 2a–c and Supplementary Figure S2), activity levels as
measured by telemetry sensor were reduced in CKD condi-
tion (Figure 8a). Therefore, Clock mutant mice showed higher
blood pressure and lower heart rate than WT mice under734adenine treatment, confirming that Clock mutation makes
mice vulnerable to the impact of the adenine diet.
DISCUSSION
This study used the adenine-induced model of kidney damage
to determine whether CKD can impact the circadian timing
system. We observed that the treated mice exhibited frag-
mented rhythms in activity and sleep, and reduction of overall
activity level. We found significant reductions in the ampli-
tude of the PER2-driven bioluminescence rhythms in the
SCN in vitro and in the kidney in vivo. Further analysis of
gene expression in the kidney using real-time polymerase
chain reaction confirmed that amplitudes of the oscillations
in a number of circadian-regulated transcripts were reduced.Kidney International (2020) 97, 728–740
Figure 6 | Urine and kidney histology of adenine-induced chronic kidney disease (CKD) in Clock mutant mice. (a,b) During the 2 weeks
of adenine (0.2%, CKD) treatment, urine creatinine and blood urea nitrogen (BUN) were measured every 4 days from wild-type (WT) and Clock
mutant mice (n ¼ 6 in each, except WT on day 13 for n ¼ 4). (c,d) After 2 weeks of adenine treatment, serum creatinine and urine
osmolarity were measured at ZT6 (Zeitgeber time; ZT0 is the time of light on and ZT12 is the time of light off). (e,f) Representative kidney
images of hematoxylin and eosin (H&E; e) and Masson trichrome staining (f) in each condition. (g) Averaged score of each pathology finding
(score level 1 for normal and level 5 for worst) in CKD mice. (h) After 2 weeks of control (Ctl) or adenine treatment, total urine volume
and urine Na/K were measured in the light and dark phase by using metabolic cages (n ¼ 7 for Ctl, n ¼ 5 for CKD in each genotype). All values
are expressed as individual plots with mean  SEM. P values, versus WT: *P < 0.05; **P < 0.01; ***P < 0.001. To optimize viewing of this image,
please see the online version of this article at www.kidney-international.org.
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Figure 7 | Matrix metalloproteinase (MMP)–2 and –9 expressions of adenine-induced chronic kidney disease (CKD) in Clock (C)
mutant mice. (a) mRNA gene expressions (Mmp-2, Mmp-9, and Tgf-b1 in the kidney; Xdh in the liver) after 2 weeks of adenine treatment in
wild-type (WT; W) and Clock mutant mice. Samples were taken at ZT6, Z12, Z18, and Z24 (Zeitgeber time; ZT0 is the time of light on and ZT12
is the time of light off; n ¼ 4 in each time point) but the all–time point samples were combined. Daily change of these gene expressions
are shown in Supplementary Figure S6. (b,c) Western blotting analysis of MMP-2 (b) and MMP-9 (c) in the kidney are shown with
representative band images (left) and relative values (right, 1 as WT mice with control [Ctl] diet). (d) Gelatin zymography of MMP-2 and
MMP-9 in the kidney with representative band images (left) and relative values (right, 1 as WT mice with Ctl diet). n ¼ 3 in Ctl, n ¼ 6 in CKD for
western blotting and zymography. All values are expressed as individual plots with mean  SEM. P values, versus WT: *P < 0.05;
**P < 0.01; ***P < 0.001. GAPDH, glyceraldehyde 3-phosphate dehydrogenase. To optimize viewing of this image, please see the online
version of this article at www.kidney-international.org.
bas i c re sea r ch H Motohashi et al.: Clock disruption in tubulointerstitial nephropathyThe CKD model also exhibited clear evidence of renal
inflammation and distal tubular dilation. Non-dipping hy-
pertension with disrupted circadian rhythm and low heart
rate was seen in the CKD model mice, confirming the
circadian disruption in this model and similarity with human
CKD patients.24 Finally, Clock mutant mice with a dysfunc-
tional circadian timing system proved to be more sensitive to
adenine-induced kidney damage than were WT controls,
which is caused by higher adenine metabolite deposition and
higher MMP expressions in the kidney.
Previous papers have shown that renal disease patients
have sleep problems, including fragmentation of sleep6 and
daytime sleepiness7 with reduced duration and intensity of
daytime physical activity.6 We found that the adenine-treated
mice did not exhibit extensive disruption or increase of their
rhythm in sleep. We did see clear evidence of fragmentation of
the rhythms in sleep and activity with decreased cage activity
(Figure 2; Supplementary Figure S2). Prior work in another
CKD model (5/6 nephrectomy rats) found decreased cage736activity and increased rapid eye movement/non–rapid eye
movement (REM/NREM) sleep in the end of the active
period, but it did not examine the fragmentation of sleep and
activity.25 Fragmented sleep in the rest period could be due to
the arousal signals of urine excretion or thirst in the CKD
mice, as the treated mice did exhibit more urination and
water-drinking behavior during their rest period. These ef-
fects are due to the downregulation of Aqp2 and V2r gene
expression in both a day– and night–24 hour period in the
adenine-treated kidney (Figure 5b). These results are consis-
tent with a previous report in which acute adenine intake (7
days) directly downregulates Aqp2, V2r, and Nkcc2 gene
expression and causes diabetes insipidus.26
We found that the treated mice exhibited reduced ampli-
tude without change of the cycle length (period) or phase in
the rhythm of PER2::LUC activity in the SCN, in vitro
(Figure 3). There may be a strain difference in the clock gene
expressions in the SCN of CKD mice. Recently, Myung et al.27
reported no effect on the PER2::LUC rhythms of adenine-Kidney International (2020) 97, 728–740
Figure 8 | Blood pressure (BP) measurement of adenine-induced chronic kidney disease (CKD) in Clock (C) mutant mice. (a) Averaged
systolic (Sys), mean, and diastolic (Dia) BP, heart rate (beats per minute [bpm]), and movement (activity) measured by the radiotelemetry
method after 2 weeks of control (Ctl) or adenine (CKD) diet treatment are shown. n ¼ 4 for Ctl, n ¼ 3 for CKD in each genotype.
Percent difference of each parameter between day and night is also shown. Individual plots are shown in Supplementary Figure S6B.
Results of cosinor analysis and 2-way repeated measures analysis of variance are shown in Supplementary Tables S2 and S3, respectively.
(b) Averaged Sys, mean, and Dia BP, and heart rate measured by tail-cuff method at ZT14–18 (Zeitgeber time; ZT0 is the time of light on and
ZT12 is the time of light off; data measured at ZT4–8 are shown in Supplementary Figure S6C). All values are expressed as individual
plots with mean  SEM. P values, versus wild-type (WT; W): *P < 0.05; **P < 0.01.
H Motohashi et al.: Clock disruption in tubulointerstitial nephropathy ba s i c re sea r chtreated C57BL/6J male mice, although these mice showed
similar disruption in locomotor activity. We do not know the
mechanisms by which peripheral kidney damage can impact
the SCN. Increased depression-like behavior has been re-
ported in adenine-induced CKD mice and 5/6 nephrectomy
mice.28,29 Interestingly, major depression has been found to
be associated with reduced gene expression rhythms in the
human cortex.30 Furthermore, the adenine treatment causes
systemic inflammation in mice and rats.19,31 A variety of
studies25 have shown that chronic inflammation can impact
the SCN and specifically reduce the amplitude of rhythms in
clock gene expression in this structure.32,33Kidney International (2020) 97, 728–740The present study uncovered strong evidence that adenine-
induced CKD model mice exhibited disrupted circadian
rhythms in the kidney, liver, and submandibular gland, using
in vivo imaging (Figure 4). Using real-time polymerase chain
reaction, we demonstrated that the low-amplitude rhythms
were seen in a variety of genes, suggesting that the circadian
clockwork is compromised in the kidney of our CKDmodel in
ICR and C57BL/6Nmice (Figure 5; Supplementary Figure S1).
Althoughwe did not see the same reduction in vitro PER2::LUC
rhythms (Supplementary Figure S3), this is because the clock
resetting effect might have happened when the explants were
put into the fresh recording medium, and resetting can happen737
bas i c re sea r ch H Motohashi et al.: Clock disruption in tubulointerstitial nephropathymore frequently if the oscillation is weakened in vivo.17 How-
ever, this result suggests that adenine-treated kidney can
oscillate normally in vitro in the fresh medium but not in vivo.
Prior work examining clock gene expression using other CKD
models (5/6 nephrectomy mice or rats) found less-consistent
effects. In those models, the amplitudes of the daily expres-
sion levels in renal Per1 and Per2 mRNAwere increased in the
mouse model and were unchanged in the rat model, and the
renal Clock mRNA level was increased throughout the entire
day in the ICRmouse model.34,35 As with the 5/6 nephrectomy
model, an increased amplitude of renal Per2 expression rhythm
was reported in unilateral ureteral obstruction–induced CKD
C57BL/6J mice.36 In contrast to the 5/6 nephrectomy or ure-
teral obstruction models, but consistent with our findings,
cisplatin-induced acute kidney injury in the proximal straight
and distal convoluted tubules showed significant reduction of
renal Per2 mRNA oscillation 72–92 hours after cisplatin in-
jection in rats and C57BL/6Jmice.37,38 Although it is difficult to
explain according to strain or species, this discrepancy among
CKD models might result from the pathology differences
among the models. Although all CKD models develop
decreased creatinine and BUN clearance with renal fibrosis, 5/6
nephrectomy induces tubular atrophy, tubulointerstitial
fibrosis, and glomerulosclerosis, whereas adenine treatment
mainly induces tubulointerstitial damage with infiltrating
leukocytes, interstitial edema, and widening of Bowman’s
space.16,19 In addition, renal weight is increased after both 5/6
nephrectomy and ureteral obstruction, but it is decreased by
adenine treatment. Taken together, reduction of Per2mRNA in
the adenine- or cisplatin-treated kidney might be a reflection of
the damage of convoluted tubules in the medulla of the kidney,
but more work is required to investigate this possibility.
The current study is the first to demonstrate accelerated
adenine-induced CKD development in Clock mutant mice
with increased MMPs and 2,8-dehydroxyadenine deposition
in the kidney, disrupted water/Na/K holding, higher blood
pressure, and lower heart rate, compared with WT mice.
Renal fibrosis was more severe in CLOCK-deficient mice with
unilateral ureteral obstruction–induced CKD, compared with
WT CKD mice.36 In this model, extracellular matrix–related
mRNA of Col1A1, Col4A1, and Ctgf, and Tgf-b1, were
significantly higher in the kidney of CLOCK-deficient CKD
mice. Increased expression of COX1/2 by transforming
growth factor-b–enhanced oxidative stress in CLOCK-
deficient mice resulted in accelerated CKD development.36
MMP2 and 9 matrix metalloproteinases regulate the extra-
cellular matrix and are related to many signals, including
inflammation, oxidative stress, growth factor, and monocyte
chemoattractant proteins, and they are elevated in CKD pa-
tients.39 In Bmal1-KO mice, MMP2 and 9 were upregulated in
remodeled arteries after arterial ligation.40 Cardiomyocyte-
specific Bmal1 knockout also increased MMP9 in the heart,
with accelerated aging and increased mortality.41 Thus, dys-
regulated MMP expression in circadian clock disruption led
to CKD development in the current study. Consistent with
these biochemical changes, blood pressure was increased738whereas heart rate was reduced in adenine-treated Clock
mutant mice. Cardiovascular events are prevalent and in-
crease mortality in CKD patients42 and in shift workers.43
Therefore, our data, along with the established literature,
support the hypothesis that the circadian disruption resulting
from CKD may further exacerbate progression of the disease.
In conclusion, the present study examined the reciprocal
relationship between circadian clocks and adenine-induced
renal dysfunction. Because young (age 2–3 months) male
mice were used in this study, the impact of aging and sex
differences are important topics for future work. Another
limitation of this study is that we used a 2-week treatment
that was not sufficient to induce fibrosis in the kidney. Our
findings do help us understand sleep and rhythm distur-
bances in adenine phosphoribosyltransferase deficiency,
which is a rare inherited metabolic disorder that leads to the
accumulation of 2,8- dihydroxyadenine and causes kidney
failure.44 More broadly, the results suggest that circadian
disruption caused by environmental factors, such as night-
time shift work or jet lag, may be a risk factor for CKD
development. In fact, female shift workers are reported to
have an increased risk of CKD.45 Finally, we speculate that
treating the circadian dysfunction in the kidney could be
helpful in ameliorating additional disease progression in
CKD. Many studies have shown that lifestyle changes, such as
light exposure, eating time, and exercise, enhance the circa-
dian system46 and could be recommended to improve kidney
health.
METHODS
Animals
All animal care and procedures, except cage activity and sleep
analysis, were in accordance with the guidelines of the Committee
for Animal Experimentation of the School of Science and Engi-
neering at Waseda University and in compliance with the law (No.
105) passed by and notification (No. 6) of the Japanese government.
Experiments were approved by the School of Science and Engi-
neering at Waseda University. The cage activity and sleep analysis
shown in Figure 2 were conducted at the University of California—
Los Angeles (UCLA) using C57BL/6N male mice purchased from the
UCLA animal core facility. The experimental protocols used in this
study were approved by the UCLA Animal Research Committee. The
UCLA Division of Laboratory Animals recommendations for animal
use and welfare, as well as the National Institutes of Health guide-
lines, were followed. ICR mice, homozygous Clock⊿19/⊿19 mutant
mice22 on the ICR background (originally C57BL/6J background,
but crossed over 15 times with ICR mice at Waseda University from
2004), and heterozygous PER2::LUC knock-in mice47 on the ICR
background were used in this study, except for the above-mentioned
sleep analysis. Mice were maintained on a 12:12 light/dark cycle
(with lights on at 08:00) at room temperature (23 C  1 C), 60%
 5% humidity. Male mice (age 2–4 months) were used in this
study, except for those in Supplementary Figure S4.
CKD model mice
We used a previously described model of adenine-induced tubu-
lointerstitial nephropathy in mice.16 In brief, CKD group mice were
fed 0.2% adenine mixed with AIN-93M (Research Diets, Inc., NewKidney International (2020) 97, 728–740
H Motohashi et al.: Clock disruption in tubulointerstitial nephropathy ba s i c re sea r chBrunswick, NJ) for 2 weeks. Control-group mice were fed the
normal AIN-93M diet. Powder diets were placed on the bottom of
the cage in the food container in most experiments, except that
pellet-type diets were used for measuring feeding pattern to improve
accuracy. More detailed information is in the Supplementary
Methods.
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